StockData
Ionis Pharmaceuticals Inc logo

Ionis Pharmaceuticals Inc (IONS) stock

IONSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 4/303% below fair value
$26.96−1.05 (-3.75%)

Close on Nov 17, 2026Market cap $4.48BP/E –Yield –

Ionis Pharmaceuticals EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Ionis Pharmaceuticals's EV/EBITDA was 199.7× on Jan 31, 2023, against 31.9× a year earlier. Over the last 4 years it ranged from 14.0× to 764.3×, with a median of 74.9×.

EV/EBITDA at the end of each year

PeriodPeriod endValueChange (pts)
2023Jan 31, 2023199.7×+16.2
2022Dec 30, 2022183.5×+126.9
2021Jan 29, 202156.6×+4.4
2020Dec 31, 202052.1×−3.4
2019Dec 31, 201955.5×−492.9
2018Jul 31, 2018548.4×+480.2
2017Dec 29, 201768.2×−141.8
2015Oct 30, 2015210.0×–

More Ionis Pharmaceuticals figures

See a number that looks wrong?